Literature DB >> 18363168

Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy.

Suma P Shankar1, John H Fingert, Valerio Carelli, Maria L Valentino, Terri M King, Stephen P Daiger, Solange R Salomao, Adriana Berezovsky, Rubens Belfort, Terri A Braun, Val C Sheffield, Alfredo A Sadun, Edwin M Stone.   

Abstract

Leber Hereditary Optic Neuropathy (LHON) is a maternally inherited blinding disease caused by missense mutations in the mitochondrial DNA (mtDNA). However, incomplete penetrance and a predominance of male patients presenting with vision loss suggest that modifying factors play an important role in the development of the disease. Evidence from several studies suggests that both nuclear modifier genes and environmental factors may be necessary to trigger the optic neuropathy in individuals harboring an LHON-causing mtDNA mutation. Recently, an optic neuropathy susceptibility locus at Xp21-Xq21 has been reported. In this study, we performed X-chromosomal linkage analysis in a large Brazilian family harboring a homoplasmic G11778A mtDNA mutation on a haplogroup J background. We report the identification of a novel LHON susceptibility locus on chromosome Xq25-27.2, with multipoint non-parametric linkage scores of > 5.00 (P = 0.005) and a maximum two-point non-parametric linkage score of 10.12, (P = 0.003) for marker DXS984 (Xq27.1). These results suggest genetic heterogeneity for X-linked modifiers of LHON.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363168     DOI: 10.1080/13816810701867607

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  51 in total

1.  [Leber's hereditary optic neuropathy].

Authors:  B Leo-Kottler; B Wissinger
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

Review 2.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

3.  Leber's hereditary optic neuropathy affects only female matrilineal relatives in two Chinese families.

Authors:  Jia Qu; Ying Wang; Yi Tong; Xiangtian Zhou; Fuxin Zhao; Li Yang; Shoukang Zhang; Juanjuan Zhang; Constance E West; Min-Xin Guan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

4.  Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand.

Authors:  Nopasak Phasukkijwatana; Bussaraporn Kunhapan; Jim Stankovich; Wanicha L Chuenkongkaew; Russell Thomson; Timothy Thornton; Melanie Bahlo; Taisei Mushiroda; Yusuke Nakamura; Surakameth Mahasirimongkol; Aung Win Tun; Chatchawan Srisawat; Chanin Limwongse; Chayanon Peerapittayamongkol; Thanyachai Sura; Wichit Suthammarak; Patcharee Lertrit
Journal:  Hum Genet       Date:  2010-04-21       Impact factor: 4.132

5.  A history of mitochondrial diseases.

Authors:  Salvatore Dimauro
Journal:  J Inherit Metab Dis       Date:  2010-05-21       Impact factor: 4.982

Review 6.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

7.  Leber hereditary optic neuropathy: bad habits, bad vision?

Authors:  Nancy J Newman
Journal:  Brain       Date:  2009-09       Impact factor: 13.501

8.  [Hereditary optic atrophies].

Authors:  C M Poloschek; W A Lagrèze
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

9.  Evidence for nuclear modifier gene in mitochondrial cardiomyopathy.

Authors:  Mercy M Davidson; Winsome F Walker; Evelyn Hernandez-Rosa; Claudia Nesti
Journal:  J Mol Cell Cardiol       Date:  2009-02-21       Impact factor: 5.000

10.  The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-hexanedione toxicity.

Authors:  Anna Ghelli; Anna Maria Porcelli; Claudia Zanna; Sara Vidoni; Stefano Mattioli; Anna Barbieri; Luisa Iommarini; Maria Pala; Alessandro Achilli; Antonio Torroni; Michela Rugolo; Valerio Carelli
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.